{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:35:31Z","timestamp":1788831331357,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Australian National Health and Medical Research Council Fellowship","award":["APP1048652"],"award-info":[{"award-number":["APP1048652"]}]},{"name":"Australian National Health and Medical Research Council","award":["APP1044941"],"award-info":[{"award-number":["APP1044941"]}]},{"name":"Australian National Health and Medical Research Council","award":["APP1062040"],"award-info":[{"award-number":["APP1062040"]}]},{"name":"Centre of Research Excellence","award":["APP1099452"],"award-info":[{"award-number":["APP1099452"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jpba.2017.10.023","type":"journal-article","created":{"date-parts":[[2017,10,25]],"date-time":"2017-10-25T05:16:38Z","timestamp":1508908598000},"page":"324-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["A UHPLC\u2013MS\/MS method for the simultaneous determination of piperacillin and tazobactam in plasma (total and unbound), urine and renal replacement therapy effluent"],"prefix":"10.1016","volume":"148","author":[{"given":"Saiyuri","family":"Naicker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yarmarly C.","family":"Guerra Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny L.","family":"Ordenez Meija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Lipman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Wallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne L.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jpba.2017.10.023_bib0005","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2165\/00003495-199957050-00017","article-title":"Piperacillin tazobactam \u2013 an updated review of its use in the treatment of bacterial infections","volume":"57","author":"Perry","year":"1999","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.jpba.2017.10.023_bib0010","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1517\/17425255.2010.506187","article-title":"Pharmacokinetic evaluation of piperacillin-tazobactam","volume":"6","author":"Hayashi","year":"2010","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"4","key":"10.1016\/j.jpba.2017.10.023_bib0015","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1128\/AAC.02747-15","article-title":"Pharmacokinetics-pharmacodynamics of tazobactam in combination with piperacillin in an In vitro infection model","volume":"60","author":"Nicasio","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.jpba.2017.10.023_bib0020","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1586\/14787210.5.3.365","article-title":"Piperacillin-tazobactam: a beta-lactam\/beta-lactamase inhibitor combination","volume":"5","author":"Gin","year":"2007","journal-title":"Expert Rev. Anti-Infect. Ther."},{"issue":"4","key":"10.1016\/j.jpba.2017.10.023_bib0025","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ijantimicag.2014.12.017","article-title":"Augmented renal clearance, low beta-lactam concentrations and clinical outcomes in the critically ill: an observational prospective cohort study","volume":"45","author":"Huttner","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jpba.2017.10.023_bib0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13054-015-0750-y","article-title":"Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?","volume":"19","author":"Udy","year":"2015","journal-title":"Crit. Care"},{"issue":"4","key":"10.1016\/j.jpba.2017.10.023_bib0035","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijantimicag.2016.06.013","article-title":"Variability of piperacillin concentrations in relation to tazobactam concentrations in critically ill patients","volume":"48","author":"Zander","year":"2016","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jpba.2017.10.023_bib0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13054-016-1348-8","article-title":"We need to optimize piperacillin-tazobactam dosing in critically ill patients-but how?","volume":"20","author":"Cotta","year":"2016","journal-title":"Crit. Care"},{"issue":"2","key":"10.1016\/j.jpba.2017.10.023_bib0045","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/CCM.0000000000002210","article-title":"Right now customized drug dosing in the critically ill","volume":"45","author":"Roberts","year":"2017","journal-title":"Crit. Care Med."},{"issue":"8","key":"10.1016\/j.jpba.2017.10.023_bib0050","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/bmc.482","article-title":"Quantitation and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC","volume":"19","author":"Arzuaga","year":"2005","journal-title":"Biomed. Chromatogr."},{"issue":"1\u20132","key":"10.1016\/j.jpba.2017.10.023_bib0055","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jchromb.2008.11.010","article-title":"High performance liquid chromatographic determination of plasma free and total tazobactam and piperacillin","volume":"877","author":"Di Giovamberardino","year":"2009","journal-title":"J. Chromatogr. B"},{"issue":"1","key":"10.1016\/j.jpba.2017.10.023_bib0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/bmc.425","article-title":"Simultaneous analysis of piperacillin and tazobactam in rabbits: application to pharmacokinetic study","volume":"19","author":"Li","year":"2005","journal-title":"Biomed. Chromatogr."},{"issue":"1","key":"10.1016\/j.jpba.2017.10.023_bib0065","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0378-4347(00)82563-3","article-title":"Determination of tazobactam and piperacillin in human-plasma, serum, bile and urine by gradient elution reversed-phase high-performance liquid-chromatography","volume":"496","author":"Ocampo","year":"1989","journal-title":"J. Chromatogr.-Biomed. Appl."},{"key":"10.1016\/j.jpba.2017.10.023_bib0070","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jpba.2016.08.010","article-title":"A simple and rapid RP-HPLC method for the simultaneous determination of piperacillin and tazobactam in human plasma","volume":"131","author":"Veillette","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"7","key":"10.1016\/j.jpba.2017.10.023_bib0075","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/bmc.800","article-title":"An improved high-performance liquid chromatographic method with a solid-phase extraction for the determination of piperacillin and tazobactam: application to pharmacokinetic study of different dosage in Chinese healthy volunteers","volume":"21","author":"Xia","year":"2007","journal-title":"Biomed. Chromatogr."},{"issue":"6","key":"10.1016\/j.jpba.2017.10.023_bib0080","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1179\/1973947814Y.0000000209","article-title":"Quantification of piperacillin, tazobactam, meropenem, ceftazidime, and linezolid in human plasma by liquid chromatography\/tandem mass spectrometry","volume":"27","author":"Barco","year":"2015","journal-title":"J. Chemother."},{"issue":"5","key":"10.1016\/j.jpba.2017.10.023_bib0085","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ijantimicag.2012.06.022","article-title":"Quantification of seven beta-lactam antibiotics and two beta-lactamase inhibitors in human plasma using a validated UPLC-MS\/MS method","volume":"40","author":"Carlier","year":"2012","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"30","key":"10.1016\/j.jpba.2017.10.023_bib0090","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1016\/j.jchromb.2011.09.031","article-title":"Development of a liquid chromatography-tandem mass spectrometry assay of six antimicrobials in plasma for pharmacokinetic studies in premature infants","volume":"879","author":"Cohen-Wolkowiez","year":"2011","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2017.10.023_bib0095","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.talanta.2012.10.046","article-title":"Development and validation of a fast and uniform approach to quantify beta-lactam antibiotics in human plasma by solid phase extraction-liquid chromatography-electrospray-tandem mass spectrometry","volume":"103","author":"Colin","year":"2013","journal-title":"Talanta"},{"issue":"9\u201310","key":"10.1016\/j.jpba.2017.10.023_bib0100","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10337-012-2214-8","article-title":"Determination of free and total piperacillin-tazobactam in plasma by HPLC-MS-MS: an adapted method for neonates","volume":"75","author":"Li","year":"2012","journal-title":"Chromatographia"},{"issue":"5","key":"10.1016\/j.jpba.2017.10.023_bib0105","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1515\/cclm-2014-0746","article-title":"Quantification of piperacillin, tazobactam, cefepime, meropenem, ciprofloxacin and linezolid in serum using an isotope dilution UHPLC-MS\/MS method with semi-automated sample preparation","volume":"53","author":"Zander","year":"2015","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10.1016\/j.jpba.2017.10.023_bib0110","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/AAC.00548-10","article-title":"Therapeutic drug monitoring of piperacillin-tazobactam using spent dialysate effluent in patients receiving continuous venovenous hemodialysis","volume":"55","author":"Connor","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2017.10.023_bib0115","series-title":"Bioanalytical Method Validation","author":"Guidance for industry [electronic resource]","year":"2001"},{"key":"10.1016\/j.jpba.2017.10.023_bib0120","series-title":"Interpretation of MS\u2013MS Mass Spectra of Drugs and Pesticides","author":"Niessen","year":"2017"},{"issue":"22","key":"10.1016\/j.jpba.2017.10.023_bib0125","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/(SICI)1097-0231(19981130)12:22<1820::AID-RCM387>3.0.CO;2-C","article-title":"Negative ion electrospray ionization tandem mass spectrometry in the structural characterization of penicillins","volume":"12","author":"Rabbolini","year":"1998","journal-title":"Rapid Commun. Mass Spectrom."},{"issue":"18","key":"10.1016\/j.jpba.2017.10.023_bib0130","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.4155\/bio.15.143","article-title":"An UHPLC-MS\/MS method for the simultaneous determination of ampicillin and sulbactam in human plasma and urine","volume":"7","author":"Parker","year":"2015","journal-title":"Bioanalysis"},{"issue":"12","key":"10.1016\/j.jpba.2017.10.023_bib0135","doi-asserted-by":"crossref","first-page":"911","DOI":"10.4155\/bio-2017-0019","article-title":"An LC-MS\/MS method to determine vancomycin in plasma (total and unbound), urine and renal replacement therapy effluent","volume":"9","author":"Parker","year":"2017","journal-title":"Bioanalysis"},{"issue":"12","key":"10.1016\/j.jpba.2017.10.023_bib0140","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1128\/AAC.00951-13","article-title":"Protein binding of beta-lactam antibiotics in critically ill patients: can we successfully predict unbound concentrations?","volume":"57","author":"Wong","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.jpba.2017.10.023_bib0145","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1097\/CCM.0b013e318241e553","article-title":"Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study","volume":"40","author":"Roberts","year":"2012","journal-title":"Crit. Care Med."},{"issue":"2","key":"10.1016\/j.jpba.2017.10.023_bib0150","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijantimicag.2012.10.002","article-title":"beta-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia","volume":"41","author":"Hayashi","year":"2013","journal-title":"Int. J. Antimicrob. Agents"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517320691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517320691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T01:26:45Z","timestamp":1731720405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708517320691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":30,"alternative-id":["S0731708517320691"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2017.10.023","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A UHPLC\u2013MS\/MS method for the simultaneous determination of piperacillin and tazobactam in plasma (total and unbound), urine and renal replacement therapy effluent","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2017.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}